BioSpace News Archive

Drug Development

Revance Completes Enrollment in ASPEN-1 Phase 3 Pivotal Trial for Cervical Dystonia

DaxibotulinumtoxinA for Injection (DAXI) has potential to be first long-acting neuromodulator for treatment of this debilitating involuntary muscle movement disorder

November 4, 2019
·
8 min read
Chronic Fatigue Syndrome Therapeutics Market - R&D of New Drugs to Boost Growth Through 2019-2023 | Technavio

Technavio has announced its latest market research report titled global chronic fatigue syndrome therapeutics market 2019-2023.

November 4, 2019
·
3 min read
Business

DURECT Corporation Announces Third Quarter 2019 Financial Results and Update of Programs

DURECT Corporation announced financial results for the three months ended September 30, 2019 and provided a corporate update.

November 4, 2019
·
15 min read
Business

NanoString Technologies Releases Operating Results for Third Quarter of 2019

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, reported financial results for the third quarter of 2019.

November 4, 2019
·
12 min read
Deals

Ensign Group Acquires Three Skilled Nursing Facilities in South Texas

The Ensign Group, Inc. announced that it acquired the real estate and operations of the following skilled nursing facilities in San Antonio, Texas

November 4, 2019
·
2 min read
Lilly to Participate in Credit Suisse 28th Annual Healthcare Conference

Eli Lilly and Company will participate in the Credit Suisse 28th Annual Healthcare Conference on Wednesday, November 13, 2019.

November 4, 2019
·
1 min read
Business

Mirati Therapeutics Reports Third Quarter 2019 Financial Results

Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, reported financial results for the third quarter ended September 30, 2019.

November 4, 2019
·
11 min read
Business

Endo Reports Third-Quarter 2019 Financial Results

Operating Performance Led by Year-over-Year Double-Digit-Percentage Revenue Growth in Sterile Injectables and in Specialty Products Portfolio of Branded Pharmaceuticals

November 4, 2019
·
14 min read
Zymeworks to Present at Stifel 2019 Healthcare Conference

Zymeworks Inc. announced that management will present at the upcoming Stifel 2019 Healthcare Conference taking place November 19-20, 2019 in New York, NY.

November 4, 2019
·
1 min read
Business

IVERIC bio to Report Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 12, 2019

Company to Host a Zimura® R&D Symposium for Investors on November 20, 2019

November 4, 2019
·
2 min read